Smoking Cessation and Mortality Trends among 118,000 Californians, 1960 Californians, -1997 James E. Enstroml and Clark W. Heath, Jr . 2J We assessed the impact of smoking cessation on subsequent death rates among a cohort of 51,343 men and 66,751 women in California enrolled in late 1959 in the original American Cancer Society (ACS) Cancer Prevention Study (CPS I) and followed for 38 years. We compared the age-adjusted death rate, expressed as deaths per 1,000 person-years, among all subjects who smoked cigarettes in 1959 but who had largely quit as of 1997 with the death rate among never smokers over a 38-year period. The all causes death rate for males decreased from 20.67 during 1960-1969 to 18 .68 during 1960-1997 for smokers and decreased from 10.51 to 9.46 for never smokers. The lung cancer death rate for males increased from 1.558 to 1.728 for smokers and increased from 0.127 to 0.133 for never smokers. The all causes death rate for females increased from 9.54 to 10.14 for smokers and decreased from 6.95 to 6.44 for never smokers. The lung cancer death rate for females increased greatly from 0.208 to 0.806 for smokers and increased from 0.094 to 0.116 for never smokers. These results indicate there has been no important decline in either the absolute or relative death rates from all causes and lung cancer for cigarette smokers as a whole compared with never smokers in this large cohort, in spite of a substantial degree of smoking cessation. While cessation clearlv reduces the mortalitv risk among long-term former smokers, ;he population irnpact'of cessatio; appears to be less than currently believed. (Epidemiology 1999; 10:500-512) Keywords: cigarette smoking, smoking cessation, mortality, lung cancer, trends, Cancer Prevention Study.
It has been estimated that cigarette smoking causes about one-fifth of all U.S. deaths.' This figure represents over 400,000 deaths per year, mainly from coronary heart disease, lung cancer, and other respiratory diseases, that in principle can be substantially reduced by smoking cessation. Nevertheless, in spite of a substantial degree of cigarette smoking cessation and a large reduction in tar and nicotine levels in ciearettes durine the c, u past 35 years in the general U.S. population,* the lung cancer death rate remains persistently high.3 Indeed, among U.S. adults since 1966 the percentage of current cigarette smokers has declined from 43% to 25% and the Dercentaee of former smokers has increased from 13% to -25%. and vet the lune cancer death rate has increased bv about 100%. Thus, it-is important to evaluate the impac; of smoking cessation from a perspective that may explain these trends.
The mortality benefits of smoking cessation are based primarily o n nonexperimental observational epidemiologic studies, which consistently indicate that the death rates of former cigarette smokers are lower than those of current cigarette smokers, and that the former smoker death rates converge toward those of never smokers the longer the former smokers have not ~m o k e d .~ Among former smokers whose smoking status was determined at the time they entered an epidemiologic study, the decline in risk of death compared with never smokers begins during the first 5 years after quitting and continues for at least 10-15 years. After 15-20 years, the risk of all-cause mortality returns nearly to that of never smokers and the risk of lung cancer mortality drops to about twice that of never smokers.
These nonexperimental studies have the limitation that the reported benefits of cessation are based on mortality patterns among persons who were already former smokers at the time they enrolled and were classified by the number of years since they last smoked at time of enrollment. The self-selected former smokers who enrolled in these studies are those who were alive at the time the study began. A former smoker who stopped 15 years before the study began is by definition one who remained alive those 15 years. Former smokers who died before the study began would obviously not be included and might be different from the self-selected former smokers who were included. Also, former smokers who have only stopped for a short time period (generally less than 5 years) and/or former smokers who were in poor health at the time of cessation do not have lower death rates than current smokers. These limitations are generally not mentioned when stating the benefits of cessation.
The most rigorous way to evaluate cessation is to assign smokers randomly to either a cessation intervention or no intervention in a randomized controlled trial (RCT). Given the evidence from nonexperimental studies, it would be expected that in an RCT with a smoking cessation intervention, smoking-related mortality would be lower in the intervention group than in the control group. There has been just one completed RCT designed to evaluate smoking cessation alone: the Whitehall Civil Servants Study of 1,445 middle aged white men in L~n d o n .T here has been one RCT where smoking cessation was the major risk factor change during 6 years of intervention: the Multiple Risk Factor Intervention Trial (MRFIT) of 12,866 middle-aged white men in A m e r i~a .T here is currently one ongoing RCT designed to evaluate smoking cessation: the Lung Health Study (LHS) of 3,702 men and 2,185 women in the United States and Canada. ' Initially these RCTs showed substantially more smoking cessation in the intervention group relative to the control group (about 45% us 20% in MRFIT averaged over 6 years, about 60% us 25% in Whitehall averaged over 5 years), but the cessation differences diminished substantially over time. For the intervention groups relative to their respective control groups, the total mortality during 16-20 years of follow-up was 6% less in MRFIT and 7% less in Whitehall; lung cancer mortality was 17% more in MRFIT and 11% less in Whitehall. No differences in total and lung cancer mortality were observed in the first 5 years of follow-up in LHS. A systematic review of nine RCTs shows that multifactorial interventions, including smoking cessation, resulted in a reduction of only 3% in total m~r t a l i t y .~ So the RCTs have not definitively confirmed the value of smoking cessation, but they are limited by the fact that they were not able to sustain a large difference in smoking cessation between intervention and control groups.
We provide additional insight into this issue in two ways. First, we analyze the conventional observational data on the benefits of cessation among a large cohort of Californians, making use of repeated measurements of smoking status and extended follow-up not previously analyzed. Second, we evaluate the "natural experiment" of long-term smoking cessation that has occurred among this cohort. Here, the smokers as a whole can be considered as an intervention group that has undergone extensive, sustained cessation and the never smokers as a whole can be considered as a control group that has never smoked. The smoking-related death rates of both groups would be expected to converge as a consequence of smoking cessation.
Although a "natural experiment" does not involve randomization of subjects and is not nearly as rigorous as an RCT, inferences about etiologic relations derived from such situations are stronger than inferences derived solely from an observational study. 9 The study of British physicians is a prime example of this approach,1° as is our somewhat similar study of California physicians." The British study involved 34,440 physicians who substantially reduced their cigarette smoking from 1951 to 1971 and whose lung cancer death rate declined relative to the general population rate and converged toward that ACS volunteer researchers to distribute and collect questionnaires from friends, relatives, and others with whom they would expect to be in contact for 6 years. A total of 1,078,000 men and women were enrolled, including 118,094 Californians (5 1,343 men and 66,75 1 women). The four-page confidential questionnaire contained data on many factors suspected as being related to cancer, such as, family history of disease; medical history; smoking, drinking, and diet; use of drugs and medicines; occupational history; and environmental exposures. In 1961 In , 1963 In , 1965 In , and 1972 , surviving subjects were asked to complete a short questionnaire regarding changes in smoking habits and detailed summaries of the smoking changes after 6 and 13 years have been publ i~h e d . '~. '~ The subjects were followed annually for 6 years, with 99% traced through September 1965. Follow-up was begun again in 1971, with 93% traced through September 1972. ACS secured death certificates from state health departments for those known dead. There were difficulties in distributing the 1972 questionnaire and only 75% of survivors returned it. Most follow-ups were terminated in 1972 because tracing became increasingly difficult owing to movement and/or death of the researchers and subjects. Follow-up was continued through 1987 for the 5% of subjects born before 1887. 17 After a 1990 feasibility study showed that it was possible to successfully follow most of the persons in a 0.3% sample beyond 1972, follow-up was undertaken on all 118,094 California CPS I subjects, excluding 22,210 deaths previously found by ACS and 6,844 persons with an incomplete or missing name who could not be followed beyond 1972. To identify new deaths, the CPS I subjects were matched several times with the 1960-1997 California death file. We evaluated death matches based on the following variables available on most subjects: last name, first name, middle initial, marital status, spouse's initials, sex, race, birth year, birth month, country of birth, county of residence, and initial health status. Follow-up was done without knowledge of the smoking status of the subjects.
To confirm that cohort members are still alive, those not known to be dead were matched by the California Department of Motor Vehicles (DMV) with Califomia driver's license information. Matches were established based on name, sex, date of birth, height, weight, and spouse's address. Other sources of follow-up have been used extensively: the Social Security death index, voter registration records, and national name and address files. Subjects are considered to be alive if they have a valid driver's license match and are not known to be dead from any source. The drivers' licenses for most of these matches were last renewed in 1995-1998. We believe most deaths through 1997 have now been identified through the above sources.
Thus, we selected a cutoff date of December 31, 1997, representing 38 years of follow-up. As of this date, among 51,343 males, there were 36,274 (71%) deaths with underlying cause known, 2,451 (5%) deaths with cause unknown (mostly outside of Califomia since 1972), 8,023 (16%) known alive through DMV records, 1,395 (3%) not followed beyond 1972, and 3200 (6%) lost as of 1997. Among 66,751 females, there were 35,183 (53%) deaths with underlying cause known, 2,030 (3%) deaths with cause unknown, 16,552 (25%) known alive, 5,449 (8%) not followed beyond 1972, and 7537 (11%) lost as of 1997.
To determine recent smoking patterns in the cohort, a mailing was done in 1994 to random samples of 200 households where both husband and wife were alive and 100 households with a single female using dri\,er's license addresses obtained from the DMV. A total of 114 men (57%) and 167 women (56%) completed a simple one-page smoking questionnaire. A second questionnaire was mailed in 1999 to 6,354 men and 12,918 women with a driver's license address as of 1995 or later. Preliminarily, a total of 2,252 (43%) men and 4,796 (45%) women completed a two-page smoking and lifestyle questionnaire, out of 5,275 men and 10,738 women who apparently received the questionnaire; at least 3,259 questionnaires were undeliverable owing to an incorrect address or recent death. Also, comparison is made with recent U.S. smoking surveys by birth cohort.ls
To determine the mortality impact of smoking cessation, we have used a survival program developed by Monson to determine person-years of follow-up, deaths and death rates by attained age, and age-adjusted death rates for attained ages 35-84, standardized to the 1960 U.S. population in 5-year age groups.19 Also, we used the Cox proportional hazards model to evaluate the age- Table 2 shows the number of subjects by age as of December 31, 1959 and 1959 smoking status, the percentage followed only to 1972, the percentage lost as of 1997, and 1960-1969 and 1960-1997 person-years of observation. The percentage withdrawn from follow-up at each age is independent of smoking status and declines with age. The person-years of observation during 1960-1997 have been 1,093,429 among men and 1,563,058 among women, making this the largest epidemiologic cohort followed for 38 years. Table 3 shows the benefits of smoking cessation based on the traditional method of examining self-selected former smokers who had quit for a number of years as of the beginning of the study. 2 The death rates for former cigarette smokers compared with never smokers have been calculated during the follow-up period 1960-1969. The death rates for those who had quit for <1 and 1-4 years were close to the death rates for current smokers, whereas the death rates for former smokers who had not smoked for 20+ years were close to the death rates for 
Current smokers (C)
Never smokers ( Table 3 show the death rate for former smokers who had not smoked for <1 year as of 1959 and those who survived for 2 years through 1961 had higher death rates than current smokers. The death rate for the former smokers who survived through 1964 was somewhat less than the death rate for current smokers. These data show that in the first few years after cessation, the death rates for former smokers are at least as high as the death rates for current smokers.
To examine the mortality risk among former smokers more closely, Table 4 These findings are consistent with a previously noted finding of the 1959 questionnaire data, namely, that around the time they answer a questionnaire a substantial number of recent quitters are in relatively poor health. 23 The poor health effect is largest in the 1st year of cessation and diminishes with each additional year of cessation before the questionnaire and each additional year of follow-up after the questionnaire. The results in Tables 3 and 4 indicate that the benefits of cessation are very limited during the first 5 years of cessation, but are substantial for those who survive many years after quitting.
The special value of this study is that it is possible to examine the overall impact of cessation on a large cohort of persons who smoked cigarettes in 1959 and then largely quit smoking during the next 38 years. This assessment is not just of long-term healthy former smokers, but of a cohort of smokers as a whole as it underwent almost total cessation, which includes both short-term and long-term quitters, a portion of whom were not healthy. Table 5 compares the death rates for an initial period, 1960-1969, when most of the 1959 smokers were still smoking, with the death rates for the entire follow-up period, 1960-1997, during which there was a substantial degree of cessation. All subjects and all 1959 current cigarette smokers are compared with 1959 never smokers for death from lung cancer and all causes. Both absolute and relative differences in death rates are presented.
When comparing the 1960-1969 and 1960-1997 periods, the death rates generally decrease slightly for all causes and generally increase substantially for lung cancer. The absolute difference in death rates between current smokers and never smokers remains relativelv constant for males but increases substantially for females. The ratio of death rates for current smokers to never smokers has remained at 1.97 for males and has increased for females from 1.37 to 1.57 for all causes. The proportional hazards ratio, based on all deaths and not just those with attained age 35-84, decreased from 1.95 to 1.74 for males and increased from 1.47 to 1.53 for females. The corresponding ratios for lung cancer remained roughly constant for males and increased threefold for females. Detailed trends in death rates for all causes are presented in 5-year intervals for current and never smokers in Appendix Tables 1-4 . Detailed comparison of death rate ratios and proportional hazards ratios by follow-up period is presented in Appendix Table 5 .
As further assessment, the death rates for all causes and lung cancer for smokers subdivided by the number of cigarettes smoked per day in 1959 are shown in Table 6 .
The death rate and ratio trends in this table are similar to those for smokers as a whole. The results in Tables   4-6 suggest that the impact of smoking cessation on cigarette smokers as a whole in this cohort is quite limited. Furthermore, it appears that the death rates for self-selected lone-term former smokers as shown in Tau ble 3 cannot be used to describe accuratelv the i m~a c t of smoking cessation on cigarette smokers as a whole.
Discussion
This study provides valuable new evidence regarding the relation of smoking cessation to the prevention of tobacco-related diseases in a large California population. First, it confirms the well-established relation that the relative risk of death among former smokers compared with never smokers decreases as the number of years quit increases based on self-selected former smokers and approaches 1.0 after 15-20 years of cessation. It shows, however, that the impact of cessation is limited during the first 5 years of cessation among these former smokers.
Furthermore, it shows that cessation has had little impact on the absolute and relative risk of total mortal. ity among all 1959 cigarette smokers compared with never smokers during the next 38 years. The relative lung cancer risk has remained essentially constant among the males and has increased markedly among the females, although lung cancer is the disease most strongly linked with cigarette smoking and is the one that should be most affected by cessation over a long follow-up period. These results help explain why there has not yet been a substantial decline in the lung cancer death rate among older U.S. males as a whole and why the lung cancer death rate among U.S. females as a whole has risen so much despite a considerable degree of smoking cessation during the past 35 years (Refs 3, 18, and Enstrom, unpublished). Our findings are similar to those found recently among U.S. male veteran smokers over a 26-year period and among a representative sample of U.S. males and females over a 19-year p e r i~d .~' ,~~ Since the impact of cessation on the smokers as a whole in this cohort is substantially less than one might have expected based on the established results for selfselected former smoker^,^,'^,^^ we have tried to identify factors that may explain this discrepancy. The results for all causes of death could be affected by lifestyle or environmental changes other than cessation that might have negated the benefits of smoking cessation, but it is not clear what these changes might have been. If cessation is accompanied by other changes that negate the benefit of cessation, these changes would have to be considered when evaluating the overall impact of cessation. It is much less likely that other changes would have affected the results for lung cancer, since cigarette smoking is by far the strongest risk factor for this disease.
Furthermore, the impact of cessation might be reduced because most of the subjects in this cohort were 45+ years of age at entry and most of the smokers were long-term smokers who quit after the age of 55 years. The heavy, long-term smokers with higher death rates probably quit later than the lighter, short-term smokers.
Also. the cohort as a whole includes all those who auit and all those who continued smoking, and healthy iersons as well as unhealthy persons with preexisting diseases. In addition, recent evidence indicates the lungs of smokers sustain permanent genetic damage that would reduce the benefits of c e~s a t i o n .~~'~~ It is not ~ossible to make a death rate com~arison of continuing smokers with auitters over the entire fol- Table 4 . This trend would suggest that if there had been no cessation, the death rates for a 1959 cohort of continuing smokers would be even larger than those observed in Table 5 . O n the other hand, such an increase mieht be moderated bv the fact that ;he death rates for current smokers converbe toward -those of never smokers with increasing age (Appendix Tables 1-4 ).
There are several limitations that we believe do not affect the findings. The limited smoking data available on the cohort since 1972 are a weakness; however, thev still support a high degree of cessation among the cohort even if the exact degree is uncertain. Substantial cessation occurred in the cohort as of 1972 and the 19941 1999 findines are consistent with numerous national " surveys that show most American smokers stop smoking as they age into their 70s and 80s. The percentage of persons lost to follow-up, 9% as of 1997, is independent of smoking status and would not substantially affect relative comparisons, although it could affect the absolute death rates in the later vears of follow-UD. This paper has presented data on the impact of smoking cessation on both the absolute and relative risk of mortality in one major cohort of Californians. Even with the reservations noted, the above findings, along with results of RCTs, suggest that the impact of cessation on mortality, particularly lung cancer mortality, among cigarette smokers as a whole is less than currently believed. The excess mortality risk associated with smoking can be avoided by never smoking and can be reduced among smokers only by becoming a long-term former smoker.
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